Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandy L Ballinger

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterationsSubotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.
Cancer Research|November 14, 2019
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter CohortsSeung Jun Shin, Elissa B Dodd-Eaton, Gang Peng, et al.
Future Oncology (London, England)|September 28, 2023
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissueAntony J Mersiades, Benjamin J Solomon, David M Thomas, et al.
BMJ Open|February 10, 2025
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 gliomaKristen McParland, Eng-Siew Koh, Benjamin Kong, et al.
BMJ Open|October 15, 2025
Integration of precision medicine into routine cancer care-protocol for the Precision Care Initiative: a research programme of effectiveness-implementation hybrid trialsShuang Liang, Skye McKay, Frank Lin, et al.
Journal of Translational Medicine|October 28, 2025
Implementation of precision medicine in treating non-communicable diseases: a systematic reviewShuang Liang, Elizabeth Kennedy, Nyree Gale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trialAdnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
JCO Precision Oncology|February 27, 2024
Cancer Risks Associated With <i>TP53</i> Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome SpectrumCristina Fortuno, Bing-Jian Feng, Courtney Carroll, et al.
The Lancet. Oncology|August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic studyMandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.
International Journal of Cancer|December 7, 2017
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patientsRoelof Koster, Orestis A Panagiotou, William A Wheeler, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterationsSubotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.
Cancer Research|November 14, 2019
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter CohortsSeung Jun Shin, Elissa B Dodd-Eaton, Gang Peng, et al.
Future Oncology (London, England)|September 28, 2023
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissueAntony J Mersiades, Benjamin J Solomon, David M Thomas, et al.
BMJ Open|February 10, 2025
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 gliomaKristen McParland, Eng-Siew Koh, Benjamin Kong, et al.
BMJ Open|October 15, 2025
Integration of precision medicine into routine cancer care-protocol for the Precision Care Initiative: a research programme of effectiveness-implementation hybrid trialsShuang Liang, Skye McKay, Frank Lin, et al.
Journal of Translational Medicine|October 28, 2025
Implementation of precision medicine in treating non-communicable diseases: a systematic reviewShuang Liang, Elizabeth Kennedy, Nyree Gale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trialAdnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
JCO Precision Oncology|February 27, 2024
Cancer Risks Associated With <i>TP53</i> Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome SpectrumCristina Fortuno, Bing-Jian Feng, Courtney Carroll, et al.
The Lancet. Oncology|August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic studyMandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.
International Journal of Cancer|December 7, 2017
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patientsRoelof Koster, Orestis A Panagiotou, William A Wheeler, et al.
Pageof 9